← Back to Patent Explorer
US4199471A Expired / Lapsed US ⏱️ 0.0 years remaining

Freeze-stable liquid blood control standard

Assignee: Individual
•
Filing: 1978-11-16
•
Granted: 1980-04-22
•
Expires: 1998-11-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A freeze-stable liquid blood control standard and method is provided for the quality control of the measurement of blood pH and gases in the clinical laboratory. The blood control standard comprises a sealed receptacle containing specially treated red cells and a gaseous head space at least equal to about the volume of the red cells. The special treatment comprises thorough washing and separating the red cells from the plasma components and mild treatment with aldehyde, slow admixture with lower aliphatic diol or triol, and retention in a buffered solution. The special treatment optionally includes treating at least a portion of the red cells with carbon monoxide. The head space comprises from 0-15% CO 2 , 0-25% O 2 and the balance N 2 and/or inert gas.

Inventors

  • 👤 Allan L. Louderback
  • 👤 Paul R. Szatkowski

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 03:24
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/96; G01N2496/00; G01N2496/05; G01N2496/70; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/102499; Y10T436/107497; Y10T436/108331

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 141 words
A freeze-stable blood control standard for the quality control of the measurement of blood pH and gases comprising a sealed receptacle containing treated erythrocytes and a gaseous head space having a volume which is at least equal to about the volume of said erythrocytes, said erythrocytes being treated by thorough washing in saline solution, mild admixing with a solution of aldehyde and saline, thorough washing in saline solution, then slow admixing with a cryoprotective agent selected from the group consisting of lower aliphatic diols and triols to a concentration of from about 20 to about 40 volume percent of said cryoprotective agent, said gaseous head space comprising from about 0% to about 15% CO 2 , from about 0% to about 25% O 2 and the balance selected from the group consisting of N 2 and inert gases and mixtures thereof.
Claim 2
Dependent Claim 141 words
A freeze-stable blood control standard for the quality control of the measurement of blood pH and gases comprising a sealed receptacle containing treated erythrocytes and a gaseous head space having a volume which is at least equal to about the volume of said erythrocytes, said erythrocytes being treated by thorough washing in saline solution, mild admixing with a solution of aldehyde and saline, thorough washing in saline solution, then slow admixing with a cryoprotective agent selected from the group consisting of lower aliphatic diols and triols to a concentration of from about 20 to about 40 volume percent of said cryoprotective agent, said gaseous head space comprising from about 0% to about 15% CO 2 , from about 0% to about 25% O 2 and the balance selected from the group consisting of N 2 and inert gases and mixtures thereof.
Claim 3
Dependent Claim 16 words
The freeze-stable blood control standard of claim 1 in which the cryoprotective agent is ethylene glycol.
Claim 4
Dependent Claim 22 words
The freeze-stable blood control standard of claim 2 in which the ethylene glycol concentration is about one-half the volume of the erythrocytes.
Claim 5
Dependent Claim 41 words
The freeze-stable blood control standard of claim 1 wherein the erythrocytes are buffered to a pH of from about 7 to about 7.7 and admixed with bicarbonate ion to a pCO 2 of from about 20 to about 55 mm Hg.
Claim 6
Dependent Claim 23 words
The freeze-stable blood control standard of claim 4 in which the buffer is selected from the group consisting of HEPES and TES buffers.
Claim 7
Dependent Claim 24 words
The freeze-stable blood control standard of claim 1 in which the aldehyde is an aliphatic aldehyde having from 1 to about 6 carbon atoms.
Claim 8
Dependent Claim 14 words
The freeze-stable blood control standard of claim 6 in which the aldehyde is formaldehyde.
Claim 9
Dependent Claim 21 words
The freeze-stable blood control standard of claim 1 in which the aldehyde concentration is from about 0.1 to about 0.6 molar.
Claim 10
Dependent Claim 31 words
The freeze-stable blood control standard of claim 1 in which the mild admixing with aldehyde is at about 20° to about 26° C. for about 15 minutes to about 4 hours.
Claim 11
Dependent Claim 38 words
The freeze-stable blood control standard of claim 1 in which at least a portion of the erythrocytes are treated with carbon monoxide and then combined with that portion of the erythrocytes that have been untreated with carbon monoxide.
Claim 12
Dependent Claim 16 words
The freeze-stable blood control standard of claim 1 in which the saline is normal physiological saline.
Claim 13
Dependent Claim 73 words
The freeze-stable blood control standard of claim 1 in which the erythrocytes are buffered to a pH of from about 7 to about 7.7, and in which at last a portion of the erythrocytes are treated with carbon monoxide and then combined with that portion of the erythrocytes that have been untreated with carbon monoxide and admixed with bicarbonate ion to a pCO 2 of from about 20 to about 55 mm Hg.
Claim 14
Dependent Claim 16 words
The freeze-stable blood control standard of claim 12 in which the cryoprotective agent is ethylene glycol.
Claim 15
Dependent Claim 14 words
The freeze-stable blood control standard of claim 12 in which the aldehyde is formaldehyde.
Claim 16
Dependent Claim 16 words
The freeze-stable blood control standard of claim 12 in which the saline is normal physiological saline.
Claim 17
Independent Claim 150 words
The method of making a freeze-stable blood control standard for the quality control of the measurement of blood pH and gases comprising thoroughly washing erythrocytes in saline solution, mildly admixing with a solution of aldehyde and saline, thoroughly washing in saline solution, then slowly admixing with a cryoprotective agent selected from the group consisting of lower aliphatic diols and triols to a concentration of from about 20 to about 40 volume percent of said cryoprotective agent, transferring to receptacles while leaving a gaseous head space of at least about equal to the volume of said erythrocytes, flushing said head space with a gas comprising from about 0% to about 15% CO 2 , from about 0% to about 25% O 2 and the balance selected from the group consisting of N 2 and inert gases and mixtures thereof, and immediately thereafter sealing said receptacles to form a gas tight closure.
Claim 18
Independent Claim 150 words
The method of making a freeze-stable blood control standard for the quality control of the measurement of blood pH and gases comprising thoroughly washing erythrocytes in saline solution, mildly admixing with a solution of aldehyde and saline, thoroughly washing in saline solution, then slowly admixing with a cryoprotective agent selected from the group consisting of lower aliphatic diols and triols to a concentration of from about 20 to about 40 volume percent of said cryoprotective agent, transferring to receptacles while leaving a gaseous head space of at least about equal to the volume of said erythrocytes, flushing said head space with a gas comprising from about 0% to about 15% CO 2 , from about 0% to about 25% O 2 and the balance selected from the group consisting of N 2 and inert gases and mixtures thereof, and immediately thereafter sealing said receptacles to form a gas tight closure.
Claim 19
Dependent Claim 77 words
The method of claim 16 in which following the admixing with the cryoprotective agent the erythrocytes are buffered to a pH of from about 7 to about 7.7, and in which at least a portion of the erythrocytes are treated with carbon monoxide and then combined with that portion of the erythrocytes that have been untreated with carbon monoxide and admixed with bicarbonate ion to a pCO 2 of from about 20 to about 55 mm Hg.

References Cited (Backward Citations)

US3876375A Cited
US3876375B1 Cited
US4056484A Cited
US4116336A Cited
US3973913A Cited
US4121905A Cited
US4126575A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1983-04-22 1983-10-22 1984-04-22 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1987-04-22 1987-10-22 1988-04-22 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1991-04-22 1991-10-22 1992-04-22 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag